|
Volumn 7, Issue 6, 2011, Pages 395-398
|
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d a,b,c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
ANTHRACYCLINE;
ANTIEMETIC AGENT;
APREPITANT;
CISPLATIN;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DIPHENHYDRAMINE;
DOPAMINE RECEPTOR BLOCKING AGENT;
FOSAPREPITANT;
GRANISETRON;
LORAZEPAM;
METOCLOPRAMIDE;
NEUROKININ 1 RECEPTOR ANTAGONIST;
OLANZAPINE;
ONDANSETRON;
PALONOSETRON;
SEROTONIN 3 ANTAGONIST;
ANTICIPATORY NAUSEA AND VOMITING;
CANCER PATIENT;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MEGADOSE;
EVIDENCE BASED PRACTICE;
HUMAN;
MEDICAL SOCIETY;
NAUSEA;
NAUSEA AND VOMITING;
PRACTICE GUIDELINE;
PROPHYLAXIS;
RADIATION INDUCED NAUSEA AND VOMITING;
SHORT SURVEY;
SYSTEMATIC REVIEW;
TREATMENT DURATION;
TREATMENT RESPONSE;
VOMITING;
|
EID: 84859463349
PISSN: 15547477
EISSN: 1935469X
Source Type: Journal
DOI: 10.1200/JOP.2011.000397 Document Type: Short Survey |
Times cited : (46)
|
References (1)
|